BioMed Research International / 2013 / Article / Tab 2 / Research Article
A Novel Differential Predict Model Based on Matrix-Assisted Laser Ionization Time-of-Flight Mass Spectrometry and Serum Ferritin for Acute Graft-versus-Host Disease Table 2 Demographic and clinical characteristics of patients with and without acute GVHD.
Case Age Recipient gender Doner gender Underlying disease Donor type Pretreatment Clinically affected aGVHD organ aGVHD grade 1 48 M F AML Related BU + CY Skin, mouth, gastrointestinal tract IV 2 36 M F AML Related BU + CY 0 3 25 M M AML Related BU + CY 0 4 47 M M AML Related BU + CY Skin, mouth 0 5 53 F F CML Related Flud + BU Gastrointestinal tract III 6 14 M M ALL Related TBI + CY + ATG 0 7 31 F F AML Unrelated BU + CY Skin I 8 15 M M AML Related BU + CY + ATG Skin, liver II 9 40 M M MDS Related BU + CY + ATG Skin, mouth, gastrointestinal tract IV 10 22 M M ALL Related TBI + CY + ATG Skin, mouth, liver, gastrointestinal tract III 11 22 M M MDS Unrelated BU + CY + ATG Skin, mouth, gastrointestinal tract IV 12 44 F F AML Unrelated BU + CY + ATG Gastrointestinal tract II 13 28 M M ALL Unrelated TBI + CY + ATG 0 14 28 M M ALL Related TBI + CY 0 16 47 F F CML Related BU + CY Skin, liver, gastrointestinal tract II 17 43 M M MDS Related BU + CY + ATG Gastrointestinal tract II 18 44 M F AML Related BU + CY Liver, gastrointestinal tract III 19 49 F F ALL Unrelated BU + CY + ATG Gastrointestinal tract II 22 15 M M ALL Unrelated BU + CY + ATG Skin I 30 23 M M ALL Related Flud + BU Gastrointestinal tract II 33 16 M F MDS Related BU + CY + ATG Gastrointestinal tract I 36 43 M M AML Unrelated BU + CY + ATG Skin I 39 27 F F CML Unrelated BU + CY Skin, mouth I 40 45 M M MDS Related BU + CY Skin I
M: male; F: female; AML: acute myelogenous leukemia; CML: chronic myelogenous leukemia; MDS: myelodysplastic syndrome; ALL: acute lymophoblastic leukemia; TBI: total body irradiation; BU: busulfan; CY: cyclophosphamide; Flud: fludarabine; ATG: rabbit antithymocyte globulin.